Yan Wang, PhD, MBA
Chief Executive Officer | Biopharma & Diagnostics Leader | M&A & Strategy Expert
USA | China
Professional Summary
Dr. Yan Wang is a globally experienced biopharmaceutical executive with more than 25 years across diagnostics, pharmaceuticals, biologics, and chemical manufacturing. With leadership roles spanning the USA, China, and Europe, he has successfully led corporate turnarounds, M&A transactions, product development, and operational scaling. A dual PhD and MBA holder, Dr. Wang brings deep expertise in strategy, business development, regulatory affairs, and cross-cultural team leadership.
Professional Experience
Chief Executive Officer, Board Director | Former Chief Technology Officer
2022 – Present
- Leads all company operations, including product development, fundraising, IP strategy, and regulatory affairs
- Wrote and submitted multiple grant proposals to government agencies and private foundations
- Oversees internal R&D teams and external partners
Cytovance Biologics Inc.
Interim CEO, Board Director
2017 – 2020
- Directed acquisition ($206M), post-M&A transition, and operational turnaround
- Rebuilt leadership team and doubled revenue in two years
- Turned net income and cash flow from negative to significantly positive
- Implemented leadership development and strategic planning initiatives
Scientific Protein Laboratories LLC (SPL)
President | Board Director | SVP, Corporate Development & Technology
1997 – 2021
- Led company to triple net income and major expansion into CDMO services
- Managed M&A transactions involving Wyeth, Arsenal Capital, American Capital, and Shenzhen Hepalink
- Oversaw post-acquisition integration and managed parent company relations
- Founded and managed SPL’s Chinese JV; led site construction, FDA approval, crisis management, and eventual exit
- Holder of six US patents; directed R&D and new product development
Stepan Company
Market Manager | Business Development – China | Research Chemist
1993 – 1997
- Managed a $60M business and led China investment strategy
- Conducted market analysis and led deal negotiations
SINOPEC Research Institute of Petroleum Processing
Engineer
1982 – 1985
- Focused on heterogeneous catalysis for lubricant production.
Education
- PhD, Organic Chemistry – University of Wisconsin–Madison
- MBA, Banking, Investment & Corporate Finance – University of Wisconsin–Madison
- BS, Chemistry – Peking University, Beijing
- Executive Education – Harvard Business School (Leading Change), Kellogg (M&A), University of Michigan (Intl. Operations)